It’s essential for those diagnosed or at risk of prostate cancer to understand the extent of healthcare coverage available to them. 

A 2018 study by the Centers for Medicare & Medicaid Services (CMS) showed that 7.3% of male Medicare fee-for-service (FFS) beneficiaries had claims associated with a prostate cancer diagnosis in 2018. With such a notable proportion of Medicare recipients affected by this condition, awareness of whether the program covers prostate cancer is critical. 

In this article, we will look into the aspects of Medicare that pertain to prostate cancer, including coverage, costs, and services available to beneficiaries. This information is invaluable for individuals seeking to navigate the healthcare system effectively while managing prostate cancer.

Does Medicare cover genetic testing for prostate cancer?

Medicare recognizes the importance of early detection in managing prostate cancer effectively. As such, Medicare Part B covers crucial screening tests for prostate cancer. For men aged 50 and above, these tests are available once every 12 months. Specifically, the Medicare Coverage Database covers the following screening tests for prostate cancer:

  • Screening Digital Rectal Examination: This examination involves a clinical check for nodules or other abnormalities in the prostate. It is a crucial part of the early detection of prostate cancer. Medicare Part B covers one screening digital rectal examination annually, provided that at least 11 months have passed since the last Medicare-covered exam.
  • Screening Prostate Specific Antigen (PSA) Blood Test: The PSA blood test is vital in detecting the presence of prostate cancer. The test measures the level of prostate-specific antigen in the blood, which is a reliable marker for prostate cancer. Medicare Part B covers one PSA blood test annually, with the same 11-month interval condition as the digital rectal examination.

These screenings are essential preventive measures and must be ordered by the beneficiary’s physician, physician assistant, nurse practitioner, clinical nurse specialist, or certified nurse.

Medicare Part B covers crucial screening tests for prostate cancer. For men aged 50 and above, these tests are available once every 12 months.

Cost of Medicare-covered prostate cancer screening

The cost for both Medicare-approved prostate cancer screening tests outlined by Medicare is:

  • For the digital rectal exam, once the Part B deductible is met, beneficiaries are required to pay 20% of the Medicare-approved amount for both the exam and the doctor’s services related to it. If this exam is conducted in a hospital outpatient setting, an additional copayment for the hospital visit is also incurred.
  • On the other hand, the Prostate Specific Antigen (PSA) blood test comes at no cost to the beneficiary on a yearly basis. However, if the chosen doctor doesn’t accept Medicare assignment, there may be an additional fee for the doctor’s services. It is important to note that this additional fee applies to the doctor’s services only and not to the test itself.

Does Medicare cover prostate surgery?

Medicare prostate cancer coverage includes prostate surgery when it’s deemed medically necessary by a healthcare professional. This includes various forms of prostate surgeries, such as robotic-assisted procedures, traditional open surgeries, and minimally invasive laparoscopic surgeries. The out-of-pocket expenses for the beneficiary would depend on whether the surgery is performed on an inpatient or outpatient basis.

How much does Medicare pay for prostate surgery?

For inpatient surgeries, Medicare Part A is applicable. In 2024, the deductible for Medicare Part A is $1,632 for each benefit period. After meeting the deductible, Medicare covers the hospital costs for the first 60 days without any additional daily coinsurance.

For outpatient surgeries, Medicare Part B comes into play. The deductible for Medicare Part B in 2024 is $240. After the deductible is met, the beneficiary is generally responsible for 20% of the Medicare-approved amount for the doctor’s services and outpatient costs.

It’s important for patients to communicate with their healthcare providers to understand which category their surgery falls under and plan for the associated costs accordingly.

Is robotic prostate surgery covered by Medicare?

Medicare maintains a non-discriminatory approach when it comes to covering various types of surgery, including robotic prostate surgery. As long as the robot-assisted surgery is deemed medically necessary and is conducted in a facility approved by Medicare, it will generally be covered. 

However, it is important to note that the surgeon utilizing the robotic equipment should also be a participating Medicare provider. This stipulation can be particularly significant when considering robotic surgeries performed remotely. Due to this requirement, Medicare beneficiaries should be aware that surgeries conducted remotely by surgeons located in foreign countries may not be covered under Medicare. It is advisable for patients to confirm Medicare prostate cancer treatment coverage details with their healthcare providers and Medicare before undergoing robotic prostate surgery.

Does Medicare cover cyberknife for prostate cancer?

In the past, Medicare’s coverage for CyberKnife treatment was limited and not available in all states. However, since January 2020, Stereotactic Body Radiation Therapy (SBRT) for prostate cancer, which includes CyberKnife treatment, is covered by Medicare in all 50 states and the District of Columbia. 

Since January 2020, Stereotactic Body Radiation Therapy (SBRT) for prostate cancer, which includes CyberKnife treatment, is covered by Medicare in all 50 states and the District of Columbia. 

Does Medicare cover HIFU for prostate cancer?

As of the present, Medicare coverage for High-Intensity Focused Ultrasound (HIFU) is typically restricted to treating tremors linked to Parkinson’s disease. Regrettably, HIFU applied to both cancerous and benign tumors, including those in prostate cancer, is not currently included in Medicare’s coverage. 

A shift in Medicare policies over recent years has led to a withdrawal of their previous broader coverage for HIFU in treating prostate cancer. Consequently, the reimbursement for facilities capable of conducting this specific procedure has also been discontinued. It’s essential for patients considering HIFU to verify their coverage status.

Does Medicare cover hormone therapy for prostate cancer?

Hormone therapy may be a part of the prostate cancer treatments covered by Medicare, depending on your plan and the medication involved. The coverage for hormone therapy is typically provided under Medicare Part D or Medicare Advantage plans. To ascertain if the specific drugs involved in your hormone therapy are covered, it is advisable to consult the formulary of your Medicare plan. 

Logo image

Find a Medicare plan based on
your needs and preferences.

Say no to pushy sales calls
Shop MEDICARE online

Model image

Does Medicare cover radiation therapy for prostate cancer?

Medicare does cover radiation therapy for all types of cancers if it is considered medically necessary for the patient. In most cases, it is conducted in an outpatient setting and is covered under Medicare Part B.

Proton Beam Therapy is a type of radiation therapy that has recently gained a lot of popularity. This therapy uses protons (tiny particles) to target and kill cancer cells. For prostate cancer, Proton Beam Therapy is still in the investigation phase, as per the Centers for Medicare and Medicaid Services. What this means is that doctors are still trying to figure out if this treatment is as good as, better, or worse than other radiation therapies, like external beam radiation, IMRT, or brachytherapy.

Medicare can cover Proton Beam Therapy for prostate cancer as part of a clinical trial, but there are some conditions:

  • The cancer should be only in the prostate and not have spread to other parts like seminal vesicles, lymph nodes, or other structures. In other words, the cancer should be in its early stages.
  • If Proton Beam Therapy is recommended, doctors need to provide proper documentation showing why it is suitable for the patient. This includes the stage of cancer and other factors.
  • The patient must be well-informed about Proton Beam Therapy and other treatment options. The patient should know what to expect, the risks involved, and the potential benefits of each treatment.

In simple terms, Medicare will help cover the costs if Proton Beam Therapy is part of a clinical trial, the cancer is in its early stages, and the patient is well-informed about the therapy.

Conclusion

Navigating through treatment options can be daunting, but it’s reassuring to know that Medicare covers prostate cancer treatments in various forms. Staying informed and consulting with healthcare professionals can help individuals make the best decisions for their health while utilizing the benefits of Medicare for prostate cancer care.

Article updated on January 12, 2024.